Both genetic and environmental factors contribute to the development of intellectual disability (ID). Previously, we identified a promoter variant (−113C>A) in PLP2 ( proteolipid protein 2) that results in an ∼4-fold reduction of transcript and protein and is overly represented in males with X-linked ID (XLID). The functional connection between reduced PLP2 expression and increased risk to XLID is unknown. To investigate the pathophysiological mechanisms, we studied a Plp2-loss-of-function murine model and fibroblasts from XLID patients hemizygous for PLP2-(−113C>A). We found that Plp2-deficient mouse embryonic fibroblast and human fibroblasts carrying PLP2-(−113C>A) have similarly defective endoplasmic reticulum (ER) trafficking, increased basal ER stress and exaggerated susceptibility to inducers of ER stress. Plp2-deficient mice show increased neuronal death to ER stress and hypoxia in vitro and in a neonatal hypoxia-ischemia model in vivo. Finally, we provide evidence that up-regulation of PLP2 directly promotes resistance to ER stressors. Results of our studies support the hypothesis that reduced PLP2 expression increase susceptibility of neurons to environmental ER stressors such as hypoxia and ischemia and that increased apoptosis and neuronal death contribute to the risks to ID in humans.
Introduction
Neonatal hypoxia-ischemia encephalopathy (HIE) contributes to injuries to the developing brain and frequently results in variable degrees of developmental delay, cerebral palsy, behavioral anomalies and intellectual disability (ID) (1, 2) . It has long been hypothesized that genetic susceptibility interacting with recognizable environmental factors contribute to increased risks, severity and neurological outcome of infants with HIE. Despite extensive investigations, conclusive genetic evidence supporting this hypothesis remains elusive (3) .
Proteolipid protein 2 (PLP2) is a small integral membrane protein of the endoplasmic reticulum (ER). PLP2 expresses abundantly in multiple brain regions including hippocampus but its function is not known. In a previous cDNA microarray-based genetic screen to identify novel genes responsible for XLID, we found a PLP2 promoter variant (−113C>A) that is over-represented in a cohort of males with XLID (4) . Further molecular studies indicate that PLP2-(−113C>A) alters the core-binding site of ETS family transcription factors and decreases the expression of PLP2 by 3-to 4-fold both in vitro and in vivo (4) . However, the function of PLP2 and how it relates to the pathophysiology of ID are unknown.
To investigate the mechanisms in detail, we produced and characterized Plp2-deficient mice and studied human fibroblasts carrying PLP2-(−113C>A). Here, we provide in vitro and in vivo evidence that PLP2 deficiency leads to increased sensitivity to ERstress agents and hypoxic-ischemic injury in both murine model and human cells. Our results support that reduced level of PLP2 leads to increased genetic susceptibility to ER stressors such as HIE and contributes to increased risks of early brain injuries and development of ID later in life.
Results
To study the molecular function of Plp2, we generated knockout mice by inserting a LacZ-neo cassette into the exon 1 of Plp2, six codons downstream of the initiation methionine (Supplementary Material, Fig. S1 ). We did not detect Plp2 transcript or protein in Plp2-deficient mice by northern blot or western blot, respectively, in samples from multiple tissues (Supplementary Material, Fig. S2A and B) . Plp2-deficient mice were born in Mendelian ratio and show normal litter size, physical growth, general appearance, ambulatory activities and mating behaviors when compared with their wild-type littermates. As expected, female mice show random X-inactivation in multiple tissues (Supplementary Material, Fig. S3C ).
Next, we derived primary mouse embryonic fibroblasts (MEFs) from the Plp2 −/Y mice (KO) and their Plp2 +/Y littermates (WT) to examine the cellular consequences of Plp2 deficiency. We noted that the peripheral ER in the KO cells seems dilated comparing to the fine network observed in the WT cells (Fig. 1A ). Exposure to thapsigargin (Thap), a selective inhibitor of the Ca
2+
-ATPase of the ER caused the ER of the KO cells to fragment and disperse, whereas the WT cells showed dilated but not fragmented ER (Fig. 1B) . This effect was specific for the ER, as there was no difference in other organelles, such as the lysosomes shown here, labeled with a LAMP-1 antibody. To confirm these observations, we performed electron microscopy on WT and KO MEFs. These ultra-structural studies showed that the ER lumen is markedly dilated in the KO cells under basal conditions (Fig. 1C, upper images) . Cells of both genotypes showed dilated and fragmented ER to a similar extent after exposure to Thap (Fig. 1C, bottom images) .
We suspected that these changes in ER morphology might reflect abnormal ER trafficking. To test this hypothesis, we used a temperature sensitive GFP tagged vesicular stomatitis virus G (ts-VSVG) protein that exits the ER at 32°C, but not at 40°C (5) . We visualized trafficking of ts-VSVG in cells labeled with fluorescent ER and Golgi makers. In WT MEFs, 15 min after shifting to the permissive temperature (32°C), most of the ts-VSVG remained in the ER but by 45 min, a substantial amount has reached the Golgi with all cells show some ts-VSVG in the Golgi. By 90 min, the ts-VSVG has reached its final destination, the plasma membrane. In contrast, in KO cells, most of the ts-VSVG remains in the ER and fails to reach the Golgi even at 90 min ( Fig. 1D-F) . ER to Golgi movement of ts-VSVG is associated with sialylation of the recombinant protein with a concomitant decrease in mobility on SDS-PAGE. After 45 min at 32°C, the lysate from WT cells showed additional band with reduced mobility consistent with sialylated ts-VSVG reaching the mid-Golgi. In contrast, in the KO cells, essentially all ts-VSVG showed faster mobility suggesting ER localization (Fig. 1F) . Taken together, these observations show that deficiency of Plp2 is associated with ER dilatation and delayed trafficking of ER proteins.
Abnormal trafficking of ER proteins may activate ER stress and, if not resolved, lead to cell death by apoptosis (6). As we did not observe significant cell death at baseline, we challenged WT or KO MEFs with various types of cell death stimuli. MEFs of both genotypes showed comparable sensitivity to VP16 (etoposide, an intrinsic pathway stimulus) and FasL (anti-Fas antibody plus cycloheximide, an extrinsic pathway stimulus) ( Fig. 2A) . In contrast, Thap leads to significantly increased cell death in KO MEFs compared with WT MEFs. Similarly, sensitivity to a different ER stressor, tunicamycin (TUN), an inhibitor of N-linked glycosylation, was also increased in the KO MEFs ( Fig. 2A) . Further, after treatment with Thap or TUN, KO MEFs displayed increased apoptotic markers, including cleaved caspase 3, and PARP, as well as specific ER stress markers, cleaved caspase12 and GRP78. Conversely, cells of both genotypes had a similar response to FasL (Fig. 2B) . Additionally, we noted increased basal level of ER stress in the KO MEFs, as evident by the increased cleavage of caspase 12 and slight induction of GRP78, which is consistent with our immunofluorescence and electron microscopy observations of abnormal ER morphology under basal conditions ( Fig. 1A-C) . Thus, we show Plp2-deficiency results in impaired ER trafficking and increased sensitivity to ER-stressinduced cell death, but does not affect sensitivity to agents that stimulate the mitochondria or Fas ligand-induced apoptotic pathways.
Previously, we identified a common human promoter variant that decreases the expression of PLP2 in fibroblasts and lymphoblasts by 4-fold (4). We next explored whether the reduced PLP2 expression in these individuals is sufficient to convey an increase in the susceptibility to ER-stress-induced apoptosis. We exposed passage number matched primary human fibroblasts of known PLP2 genotype to Thap or TUN and found that after treatment fibroblasts from two males hemizygous for the PLP2-(−113C>A) variant showed large vacuoles that filled the cytoplasm, whereas fibroblasts from males hemizygous for the wild-type allele showed only minimal changes under the identical condition (Fig. 2C) . Consistent with the result of the KO MEF cells, fibroblasts hemizygous for the PLP2-(−113C>A) variant also exhibited 3-fold higher cell death when exposed to Thap and no difference in response to Fas ligand. Unlike the MEFs, however, these human fibrobalsts with decreased PLP2 showed a small difference in sensitivity to VP16 (Fig. 2D) . Our results indicate that despite the residue PLP2 expression, human fibroblasts hemizygous for the PLP2 promoter variant phenocopy the KO mice at least at We then sought to test if increased levels of PLP2 may protect cells from ER-stress agents. We used HEK 293 cells for their low level of endogenous PLP2 and a sensitive apoptotic response to ER-stress-inducing agents. We established a stable HEK 293 cell line that expresses PLP2 from a single locus under the control of doxycycline induction (Flp-In T-REx HEK293-PLP2). In the presence of doxycycline, PLP2 is induced to ∼10-fold higher than baseline at the protein level (Fig. 2E) . As expected, this high level of PLP2 expression did not affect sensitivity to VP16 or FasL, but dramatically decreased cell death in response to both Thap and TUN (Fig. 2F) . This result strongly supports our hypothesis that levels of PLP2 influence the cellular response to ER stress. It further suggests that therapeutic intervention to enhance PLP2 expression at critical developmental stages may be beneficial for humans carrying the PLP2-(−113C>A) promoter variant.
Bear in mind the human ID phenotype we have associated with the common promoter variant of PLP2, we extended our study to 7-day primary cultures of cortical neurons isolated from the WT and KO embryos, and exposed the cells to either TUN or STS (staurosporine, a broad-spectrum kinase inhibitor, intrinsic pathway). Consistent with the MEF studies, Plp2-deficient neurons (KO) displayed increased sensitivity to TUN, but not to STS (Fig. 3A) . ER stress is an integral component of hypoxia-ischemia neuronal injury (7). We next attempted to simulate conditions that mimic ischemia-reperfusion injury in culture; primary cortical neurons were transiently exposed to medium containing 20 m 2-deoxy-glucose and 5 m KCN for 1 h, then allowed to recover in standard medium for 24 h (8). Plp2-deficient neurons displayed a significant increase in cell death induced by these culture conditions compared with WT neurons (Fig. 3A) .
Hypoxic-ischemic injury during neonatal period is a common cause to developmental delays and ID in humans. Because HIE is a known ER stressor (7), we thus explored if reduced PLP2 expression contributes to increased risks and severity of neuronal death and brain damage caused by HIE. To study potential effects of HIE in vivo, we used an adaptation of the Vannucci neonatal hypoxicischemic model for rodents (9, 10) . We subjected WT and KO littermates (n = 12) at postnatal day 7 (P7) to permanent unilateral common carotid artery (CCA) ligation, followed by hypoxia for 90 min in 8% oxygen. We sacrificed the mice and harvested their brains for analysis 5 days after the insult (Fig. 3B-F) . We measured the hippocampal area in eight consecutive serial sections 400 µm apart through the caudal diencephalons and calculated the ratio of ipsi-lateral versus contra-lateral hippocampal area. At all levels, this ratio in the KO is smaller than that of the WT suggesting more pronounced tissue loss (Fig. 3C ). We also derived the volume ratios of the ipsi-lateral versus contra-lateral hippocampi from the area ratio and distance between consecutive sections. The volume ratio of the KO was 0.45, indicating the injury reduces hippocampal volume by about half, whereas the volume ratio in the WT littermates was 0.95, indicating the injury barely reduces hippocampal volume (Fig. 3D) . Thus, the volume of injury following hypoxic-ischemic injury in the KO animals (55%, 1-45%) is ∼10 times higher than that of the WT littermates (5%, 1-95%). Consistent with this finding, we observed markedly increased apoptosis in the ipsi-lateral hippocampi of the KO mice when compared with their wild-type littermate controls by TUNEL staining (Fig. 3E and F) . We conclude that Plp2-deficiency results in greatly increased sensitivity to hypoxic brain injury in vivo.
Discussion
In these studies, we show that PLP2 regulates the cellular response to stimuli that converge on the ER-stress pathway. Plp2 deficiency leads to abnormal ER trafficking, which perturbs ER homeostasis, and renders the ER more susceptible to further environmental stress. We provide evidence that Plp2 deficiency confers increased susceptibility to apoptosis elicited by known ER stressors in mice both in vitro and in vivo. We further demonstrate that human fibroblasts carrying a common PLP2 promoter variant causing reduced PLP2 expression have similar cellular phenotype to what we observed in Plp2-deficient embryonic fibroblasts and neurons in mice. Importantly, our data show that overexpression of PLP2 protects the cells from ER-stress-induced apoptosis, suggesting PLP2 actively alleviates the cellular stress.
In our previous study, we found that PLP2-(−113C>A) is significantly enriched in a large cohort of males with XLID (5.85%) when compared with matched normal control males (1.56%) (4). The minor allele frequency (MAF) observed in our control population is corroborated by data from the 1000 genome project, which showed an MAF (rs.41298450) of 1% overall, 2% in CEU and not found in African descent in Southwest USA. These findings indicate that PLP2-(−113C>A) is present at a lower frequency in males with apparent normal cognitive function and is unlikely to be a Mendelian cause for ID.
Our current studies provide strong evidence that PLP2-(−113C>A)-mediated reduced expression conveys an increased susceptibility to ER stress. Among the common environmental ER stressors, perinatal HIEs frequently result in severe neurodevelopmental defects including ID. Our studies using a Vannucci neonatal hypoxic-ischemic model support that Plp2 deficiency in mice is a risk factor to neuronal apoptosis after HIE.
Together, genetic and functional data from our studies suggest that PLP2-(−113C>A) conveys an increased risk to ID through a mechanism of increased neuronal death in crucial brain regions post environmental ER stressors such as HIE. Therapeutic manipulation through this transcription factor binding site (−113C>A) could potentially enhance the expression of PLP2 and protect the neurons from ER-stress-induced apoptosis, and thus, may improve the neurological outcome of some of these susceptible individuals following an episode of HIE. Further investigations in these areas are clearly warranted.
Materials and Methods
Additional information can be found in the Supplementary Materials.
ER trafficking assay
WT and KO MEFs were transiently transfected with pEGFP-N1-ts-VSVG by electroporation, plated onto coverslips and allowed to recover at 37°C for 5 h. Cells were then incubated at the non-permissive temperature (40°C) for 12 h, before switching to the permissive temperature (32°C) for the indicated times. Cells were harvest at the indicated times for immunofluorescence staining or western blot.
Cells death assay
Apoptosis is scored by nuclear morphology. The cell count results are data from three independent experiments each with duplicated samples. In each experiment, slides were blinded for genotype and treatment, and at least 400 cells were counted from each slide for each data point.
Neonatal hypoxic-ischemic brain injury model P7 mice was subjected to right CCA ligation followed by 8% O 2 for 90 min. The brains were harvested 5 days later, fixed in formalin and embedded in paraffin. We made serial 5 µm coronal sections throughout the caudal diencephalons region at 400 µm intervals and stained the sections with trichrome. Images were processed using ImageJ (http://rsb.info.nih.gov/ij/). The hippocampal areas were measured and ipsi-/contra-lateral ratios were calculated at eight coronal levels, and the ratio of volume was calculated.
Statistics
Data are shown in mean ± SEM, Student's t-test was used to compare two groups; except for human fibroblast cell death assay, as n = 2 for the −113C>A genotype, data are presented as mean ± range for this experiment (Fig. 2D) . A P-value of <0.05 is considered significant.
Supplementary Material
Supplementary Material is available at HMG online.
